346 related articles for article (PubMed ID: 16680151)
21. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
22. PML4 induces differentiation by Myc destabilization.
Buschbeck M; Uribesalgo I; Ledl A; Gutierrez A; Minucci S; Muller S; Di Croce L
Oncogene; 2007 May; 26(23):3415-22. PubMed ID: 17146439
[TBL] [Abstract][Full Text] [Related]
23. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
Condemine W; Takahashi Y; Le Bras M; de Thé H
J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
[TBL] [Abstract][Full Text] [Related]
24. Selective activation of NFAT by promyelocytic leukemia protein.
Lo YH; Wu CC; Shih HM; Lai MZ
Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125
[TBL] [Abstract][Full Text] [Related]
25. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
[TBL] [Abstract][Full Text] [Related]
26. The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage.
Salomoni P; Bernardi R; Bergmann S; Changou A; Tuttle S; Pandolfi PP
Blood; 2005 May; 105(9):3686-90. PubMed ID: 15626733
[TBL] [Abstract][Full Text] [Related]
27. Promyelocytic leukemia (PML) protein plays important roles in regulating cell adhesion, morphology, proliferation and migration.
Tang MK; Liang YJ; Chan JY; Wong SW; Chen E; Yao Y; Gan J; Xiao L; Leung HC; Kung HF; Wang H; Lee KK
PLoS One; 2013; 8(3):e59477. PubMed ID: 23555679
[TBL] [Abstract][Full Text] [Related]
28. PML: a tumor suppressor that regulates cell fate in mammary gland.
Li W; Rich T; Watson CJ
Cell Cycle; 2009 Sep; 8(17):2711-7. PubMed ID: 19652541
[TBL] [Abstract][Full Text] [Related]
29. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
[TBL] [Abstract][Full Text] [Related]
30. CK2 and PML: regulating the regulator.
Lallemand-Breitenbach V; de Thé H
Cell; 2006 Jul; 126(2):244-5. PubMed ID: 16873055
[TBL] [Abstract][Full Text] [Related]
31. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
[TBL] [Abstract][Full Text] [Related]
32. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
[TBL] [Abstract][Full Text] [Related]
33. Pml represses tumour progression through inhibition of mTOR.
Bernardi R; Papa A; Egia A; Coltella N; Teruya-Feldstein J; Signoretti S; Pandolfi PP
EMBO Mol Med; 2011 May; 3(5):249-57. PubMed ID: 21387562
[TBL] [Abstract][Full Text] [Related]
34. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
[TBL] [Abstract][Full Text] [Related]
35. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
36. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.
Radu A; Neubauer V; Akagi T; Hanafusa H; Georgescu MM
Mol Cell Biol; 2003 Sep; 23(17):6139-49. PubMed ID: 12917336
[TBL] [Abstract][Full Text] [Related]
37. Interactions between coilin and PIASy partially link Cajal bodies to PML bodies.
Sun J; Xu H; Subramony SH; Hebert MD
J Cell Sci; 2005 Nov; 118(Pt 21):4995-5003. PubMed ID: 16219678
[TBL] [Abstract][Full Text] [Related]
38. Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer.
Vasko V; Saji M; Hardy E; Kruhlak M; Larin A; Savchenko V; Miyakawa M; Isozaki O; Murakami H; Tsushima T; Burman KD; De Micco C; Ringel MD
J Med Genet; 2004 Mar; 41(3):161-70. PubMed ID: 14985374
[TBL] [Abstract][Full Text] [Related]
39. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
Doucas V; Tini M; Egan DA; Evans RM
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561
[TBL] [Abstract][Full Text] [Related]
40. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
